A large number of highly profitable brand drugs, produced by top pharmaceutical manufacturers, are due to lose patent exclusivity, providing opportunities for generic drug manufacturers to make copies of these off-patent drugs. In addition, biotechnology offers new potential to brand and generic manufacturers alike. The challenge for the future will be continued innovation to replenish increasingly dry drug pipelines.
Seventeen emerging economies from South America, South East Asia and Eastern Europe are becoming increasingly attractive to pharmaceutical companies in the quest for geographical expansion and a wider outreach for their products. Indeed, these emerging markets for pharmaceuticals often referred to as “pharmerging” markets are occupying an increasingly larger role on the global pharmaceutical market, demonstrating double-digit compound annual growth rates.
ITC publishes a market report on a bimonthly basis covering industry trends, price information, regional and/or product profiles, industry news, regulatory updates and relevant trade events for major international markets. Price information is available for over 200 pharmaceutical starting materials and back editions dating to 1992 are also available. To download and view a sample report in pdf free of charge, click here.
Here are links to other agencies that provide further information related to pharmaceutical starting materials and the production of drugs: